Alzheimer's therapy flops in phase III clinical trial
Science AAAS
Swiss pharmaceutical giant Roche announced today it is ending a phase III clinical trial for the experimental drug gantenerumab, a monoclonal antibody therapy, because the drug has failed to actually help prevent Alzheimer's disease, Bloomberg reports.

and more »


More...